The Alternative Products Expo arrives in Fort Lauderdale March 11-13 to feature the scope and potential of all innovative products and services of the alternative products ecosystem. Organized by ZJ Events, the event group is committed to bringing the industry’s best alternative products traders, vendors, and enthusiasts under one roof, while offering a fun and exciting experience. Having conducted its CBD shows in the top cities of America, ZJ Events is all set to host an exciting new event in Fort Lauderdale, The Alternative Products Expo. The alternative product category includes herbal products, mood enhancers, cannabis derivatives, vape products, energy boost, and dietary supplements, to name. Products in the alternative category comprise products that are disrupting the traditional products; they are either substitutes for better-known products or there are no substitutes for them in the mainstream category. Exhibitors can showcase their products at dedicated booths and opt for sponsorships to conduct advertising to drive traffic to their booths wherein they impart extensive information regarding their products and services. There will also be several show specials to offer discounts on wholesale pricing for store owners. The products/services can be exhibited under the following Industry types: Accessories (Glass, Rolling papers, etc), Cannabis and cannabis derivatives such as CBD, hemp, delta8 and more, Dietary supplements, functional beverages, herbal products, kratom, mushrooms, nicotine replacements, nootropic, psychedelics, service providers, vape, and others. Thought leaders at the event will discuss vital topics and share valuable information about the latest market trends of the growing alternative product ecosystem. The conference offers a huge arena for joint venture collaborations and gives attendees direct access to connect with worldwide cannabis industry leaders who share their vision about the future scope of these products. The Alternative Products Expo includes keynotes, discussions, and workshops from eminent industry personas who will share important insights and education about the latest trends in the alternative products ecosystem. This event is a suitable platform for new businesses and traders to explore and discover long-term business opportunities in this niche. The participants can enroll as a speaker at The Alternative Products Expo. The influential speaking faculty includes an impressive lineup of industry thinkers, professionals, and executives who have immense knowledge and experience in the alternative products field which they will share with the attendees of the conference. With the growing inclination towards the alternative products category, vendors, and new businesses can connect with established traders and build long-term ties that are beneficial for the success of their company. For more information, please visit https://altproexpo.com/.

• Pluaris automates reading and analysis of textual data
• The app puts the power of data science into the hands of a wide range of consumers
• The platform is designed to help users who need to learn the most in the least amount of time

Knowledge workers, lifelong learners and teams and enterprises all stand to benefit from Nowigence’s Inc. (NOWG) focus on simplifying the challenges of learning. Recognizing the increasing demand for a quick, accessible solution to the overwhelming amount of information available in today’s world, the company created Pluaris(TM). The cloud-based app automates reading and analysis of textual data so users can learn more in less time, uncover hidden insights, and stay on top of the information they need to know. Pluaris integrates state-of-the-art data-processing techniques in an intuitive interface that puts the power of data science into the hands of a wide range of consumers. Nowigence has shared several user-success stories, showing the app’s diverse power and appeal (https://ibn.fm/PMScd). For knowledge workers who need to learn the most in the least amount of time, Pluaris automatically retrieves and analyzes publicly available reports, news and analysis on selected topics of interest every day. Users can then scroll through an annotated news feed on their phones, tablets or laptop whenever it is most convenient. “A Pluaris enterprise customer was interested in tracking news and events in the telecom industry,” the company reported. “The customer was able to quickly create and then fine-tune a list of topics to monitor. In just two days, she had an annotated news feed covering the telecom industry available for her whole team.” Another customer was already using Pluaris for business reasons when he decided to focus on improving his health, so he turned to Pluaris on a personal level. He uploaded research reports to Pluaris, read through the summaries and explored the annotated labels. He then set up Pluaris to monitor topics such as “lowering fasting blood sugar” and “low glycemic food.” The company reported that from those results, the Pluaris user built an action list of daily habits for diet and fitness and, within a couple months, brought his fasting blood sugar level down. As for enterprise users, Nowigence shared the instance of a Pluaris user at one of the world’s largest aluminum-mining companies whose manager had assigned her to prepare talking points for an upcoming investor meeting. “Using Pluaris, she had over time built a database of documents, including transcripts, notes, Q&A sessions, speeches and internal documents, some of which were from previous investor meetings,” the company stated. “She was able to quickly explore that knowledge base through the Pluaris Dashboard, drilling down using various filters. She quickly pulled this information together in a Pluaris Notebook and shared the note directly with her boss.” The ways to use Pluaris are almost unlimited, and the SaaS platform is flexible, accessible and affordable. For more information, visit the company’s website at www.Nowigence.com. NOTE TO INVESTORS: The latest news and updates relating to Nowigence are available in the company’s newsroom at https://ibn.fm/NOW

• Rare cannabinoids are cannabinoid compounds other than CBD and THC which are not yet produced in large scale but which have potentially greater benefits
• InMed acquired BayMedica in October 2021, bringing on board unmatched expertise in large-scale bio-production technologies applicable to rare cannabinoids
• As a result of this acquisition, InMed, already a leader in the production of rare cannabinoid CBC, is now in the unique and highly desired position to undertake large-scale production of other rare cannabinoids, with applications as wide as the current CBD market
• The company plans to launch new rare cannabinoid products in the first half of 2022

The human body naturally produces cannabinoids – endocannabinoids such as anandamide (“ANA”) – as part of a physiologic system that maintains human health by reducing inflammation and promoting homeostasis (https://ibn.fm/TavdM). So named after the plant that led to its discovery, the endocannabinoid system (“ECS”) however only produces two known cannabinoid compounds, while over 140 variants can be found in the cannabis plant, most in trace amounts. Of the latter group of cannabinoids, cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”) are the most common. Researchers have in fact studied both of them for decades, with studies showing that THC is the primary active ingredient in cannabis, followed by CBD. “Although CBD and THC make up most of the content in cannabis plants, they are not the only compounds that matter. The plants also have many rare cannabinoids with potential health and manufacturing uses that can now be studied,” a 2021 Forbes article reads (https://ibn.fm/J50nM). Studies now suggest that these “rare cannabinoids” could offer more potent medical benefits than CBD and without the psychoactive attribute of THC, representing a huge market. However, unlike the abundant THC and CBD products already covering the marketplace, rare cannabinoids are extremely difficult to extract from the cannabis plant and have therefore not been looked at more closely to ascertain their medical benefits. In understanding the immense potential of rare cannabinoids, InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates as well as manufacturing and delivering high-quality rare cannabinoids for a variety of uses, sees these rare cannabinoids as having applications as wide as CBD and THC. This is a hot topic in the industry. However, the industry-wide problem has always been to obtain the production scales necessary for cost-effective commercialization of such compounds, while also ensuring the purity and consistency that can be difficult at even low volumes. The answer is to develop and apply successful large-scale bio-synthesis capabilities, technologies that are complex and not readily available for these rare compounds. In October, the company celebrated a huge milestone that cemented its status as a leader in this rapidly developing field. It completed the acquisition of Bay Medica, a U.S.-based private company that specializes in the development of large-scale manufacturing and commercialization of rare cannabinoids (https://ibn.fm/RZaFE). The company has amassed an unmatched talent pool of large-scale synthetic production expertise from the industry that can be applied to rare cannabinoids. The acquisition complements InMed’s efforts within the pharmaceutical industry by adding BayMedica’s synthetic biology and chemical synthesis capabilities and expertise, in what would provide InMed with complete rare cannabinoid manufacturing flexibility to select the most appropriate, cost-effective method based on the target cannabinoid and applicable quality specifications for the desired industry. “[BayMedica has] been deploying different manufacturing techniques such as chemical synthesis, yeast biosynthesis, and InMed has not only bacterial biosynthesis but also a new approach called enzymatic biotransformation – our IntegraSyn(TM) system,” stated InMed CEO Eric A. Adams during the 2022 Edison Open House Global Healthcare Conference held on January 25 (https://ibn.fm/cLV9z). “I think we are the only company out there that can offer a full slate of these different manufacturing technologies. That’s important because no one technology is best for the whole spectrum of different cannabinoids… So, we are now in a unique position to pick and choose whatever the lowest cost manufacturing technology is for any one of these different cannabinoids,” added Adams. InMed believes it is currently the leader in large batch production of the rare cannabinoid cannabichromene (“CBC”) and is confident it can apply this manufacturing technology to create, at a larger scale, key rare cannabinoids, such as cannabidivarin (“CBDV”) and tetrahydrocannabivarin (“THCV”), on which it is currently focusing its attention. Earlier this year, InMed announced the launch of the rare cannabinoid cannabicitran (“CBT”) into the health and wellness sector, marking the first of several new product launches planned for the first half of 2022 (https://ibn.fm/idE7P). For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

• Investors are taking disparate approaches to gold as unusual inflation pressures raise questions about economic safeguards but the U.S. government continues to tout fiat strength amid employment positivity
• StraightUp Resources enters 2022 with a tailwind driving enthusiasm about its gold prospects in Ontario’s famed greenstone belt and a historically metal-rich region in the western United States
• In China, jewelry markets are beginning to recover from the COVID-19 pandemic’s darkest days, reporting a 44.99 percent year-over-year jump in consumer purchases of gold jewelry largely responsible for driving up the larger gold market
• StraightUp recently announced approval of an early exploration permit for a portion of its RLX North property, heralding activity this summer on the adjacent RLX North and RLX South exploration sites

Gold investment has become a betting man’s game as highest-in-a-generation inflation prompts renewed interest in the precious metal as a safe haven while governmental interest rate-boosting policies deflate the momentum toward non-interest yielding gold (https://ibn.fm/i8llv). While analysts generally expected that the COVID pandemic and world governments’ monetary stimulus response would induce inflation (https://ibn.fm/qbKaT), the U.S. Federal Reserve’s hawkish support of fiat currency by announcing proposed interest rate increases beginning in March has tempered interest in gold (https://ibn.fm/KOCZ6). Among the potential wildcards to be pulled from the deck: Gold is more than just an asset — the nearly indestructible metal has diverse uses, including in jewelry and technology (https://ibn.fm/BMoaX). Gold jewelry consumption fell precipitously during the early stages of the COVID-19 pandemic, but a nascent emergence from COVID’s darkest hours includes the recovery of the jewelry market as exemplified in recent news about the jump in gold consumption in China, led by rising jewelry purchases at a rate of 44.99 percent YOY and a 26.87 percent increase in gold bar and coin consumption (https://ibn.fm/0VOI2). Precious metals explorer and property asset class holder StraightUp Resources (CSE: ST) (OTCQB: STUPF) is bullish on the possibilities of its portfolio options and acquisitions in historically gold-and-silver rich regions. The Canada-headquartered mineral explorer has spent the last year steadily increasing its data on five gold properties it has optioned in Canada’s well-known greenstone belt in Ontario, as well as a gold and silver mine it acquired in the western United States. High-resolution heli-borne magnetic surveys (“MAGs”) and the subsequent ground investigation efforts at the Ontario Red Lake area properties have confirmed “multiple areas of high merit and potential mineralization” (https://ibn.fm/ByCxz) on one of the sites, known as the Ferdinand Gold Project, which consists of 17 contiguous mining claims covering 7,143 hectares (17,651 acres). On Jan. 13, the company announced approval of an early exploration permit for a portion of its RLX North property within the greenstone belt. The permit for mechanized drilling in the property’s eastern sector will be valid for three years, allowing StraightUp Resources to move forward with its 2022 work programs, which is expected to include drilling of the most prospective targets this summer, the company stated (https://ibn.fm/Alx4L). President Mark Brezer remarked that the company is in position to set up drill programs on both the RLX North property and the adjacent RLX South property, distinguished by changes in the underlying geology between each of them that are separated by two “metavolcanic packages” that StraightUp believes are highly prospective for economic deposits of gold. “The latest results, combined with our extensive data set from previous exploration, strengthen our commitment to the Red Lake Mining District and its potential for legendary, high-grade gold discoveries,” Brezer stated. “Local expertise is continuing to prove itself invaluable to our exploration goals.” StraightUp extended its investor reach in November by joining its Canadian Securities Exchange listing with a new listing on the OTCQB Venture Market in the United States. “I expect our shareholders to benefit through increases in trading liquidity and expanded retail and institutional investors,” Brezer said at the time (https://ibn.fm/K7vaL). For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

• As the number of older Americans moves to exceeding the number of children, analysts are forecasting the U.S. hearing aid market to grow 69% to $4.48 billion in 2028
• InnerScope Hearing Solutions is using a strong mix of Direct-to-Consumer and a retail footprint to market and sell its affordable, app-controlled hearing aids
• InnerScope recently acquired HearingAssist, making INND Walmart’s largest direct-ship and wholesale hearing aid supplier a two-prong stock purchase where the second leg gives INND a market cap of $1+ billion

Looking for overlooked market segments on Wall Street? Look to your elders. The U.S. Census Bureau (“USCB”) shows that the country is charting a course for older adults to outnumber kids for the first time ever. That means a growing number of cases of presbycusis, or age-related hearing loss. Luckily, today’s graying generation won’t have to use the bulky hearing aids of old; they can benefit from technological advancements from companies like InnerScope Hearing Technologies (OTC: INND) that make testing easier and hearing devices more discrete and affordable than ever before. Owing in part to younger generations having fewer children and people living longer, USCB sees the country reaching a milestone in 2034 when the number of people over age 65 outnumber those under age 18, approximately 77 million to 76.5 million. Data from the National Institute on Aging shows that about one in three people between the ages of 65 and 74 suffer from hearing loss, a figure that jumps to nearly 50 percent for people aged 75+. Against that backdrop, it’s not hard to understand why Fortune Business Insights forecasts the U.S. hearing aids market to grow 69% from $2.65 billion in 2021 to $4.48 billion in 2028. Other market research firms, including Allied Analytics and Market.us, see multiple drivers for continuous market expansion. InnerScope is on the leading edge of technology, delivering premium hearing products for lower prices, including app-controlled hearing aids (quick adjustments are made using a smartphone), hearing amplifiers, associated cleaning goods and vitamins through a direct-to-consumer (DTC) model that includes subscription plans so aging consumers don’t forget to order their goods. To get the process rolling, InnerScope offers a free online hearing test at www.MyHearIQ.com. The company also is establishing a strong brick-and-mortar retail presence. InnerScope’s wholly owned subsidiary, HearingAssist, is Walmart’s largest direct-ship and wholesale hearing aid supplier. InnerScope closed the acquisition of HearingAssist in late in November, bringing on board a company that has generated more than $72 million in revenue since 2018. InnerScope bought HearingAssist in an all-stock deal split into two price points for the stock, including the second tranche at $0.17 per share that equates to a market capitalization more than $1 billion. Last month, HearingAssist received purchase orders from Walmart totaling over $277,000 for its EZ-Hear Neckband Bluetooth Hearing Amplifier for in-store displays in 757 Walmart Stores across five states. Furthermore, InnerScope recently formed a partnership with grocery and pharmacy chain Giant Eagle. Per the deal, InnerScope’s automated self-check hearing screening kiosks are being installed in select Giant Eagle stores throughout Pennsylvania and Ohio. The Giant Eagle deployment was announced a week after InnerScope inked a deal with Food City Pharmacy to put the kiosks in three stores across Virginia and Tennessee, while incentivizing customers exclusive discounts for InnerScope products ordered through the Food City website. While it keeps churning out fundamental developments, the company recently took a moment to speak to investors with CEO Matthew Moore accepting an invitation to present at the Emerging Growth Conference earlier this month. For more information, visit the company’s website at www.INND.com. NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

• FingerMotion attributed its strong finish for Q3 2022 to strategic investments and collaborations with key players in the industry
• It hopes to carry on this performance trend into the next fiscal year, tapping into the investments and collaborations made so far
• The company also plans to capitalize on the insurtech sector while also forming new brands designed to offer mobile device protection for the Chinese market

FingerMotion (NASDAQ: FNGR), recently released its financial results for the third quarter of the 2022 financial year (“Q3 2021”), posting a 21% growth in revenue from the same period in 2020. Martin Shen, the Chief Executive officer (“CEO”) of the company, termed this a “strong finish” while also expressing his optimism for even better performance in the next fiscal year (https://ibn.fm/iWS7u). This growth for Q3 2022 was attributed to the company’s strategic investments and collaborations with key players in the industry, most notably China Mobile in the Fujian province. “The third quarter finished strong with $5.9 million in revenue and an acceleration of our top-up business,” Mr. Shen noted. “During the quarter, we were aggressive in rolling out our collaboration with China Mobile in Fujian province,” he added. Gross profit for Q3 2022 stood at $967,075, representing a 56% year-over-year growth from the same period the previous year. In addition, its Telecommunications Products and Services business posted total revenue of $2.8 million, a 580% year-over-year quarterly growth from the same period in 2020. FingerMotion closed the 2021 calendar year with significant investment into its insurtech sector. Its services agreement with Pacific Life Re, through its big data analytic division, Sapientus, coupled with its collaboration with Xuanlian Tianxia Technology and Happy Life Insurance, make it a formidable force in the Insurtech space. Mr. Shen is confident that in the new year, revenue should ramp up as the insurtech business starts to unfold, all while tapping into the big data in the insurance market that is projected to be valued at $12 billion by 2023 (https://ibn.fm/dE4dz). The company has also formed new brands designed to offer mobile device protection in China, with Beta testing already underway. Mr. Shen is optimistic that this investment will represent a significant revenue stream in the next fiscal year, even as it works on other aspects of its operations, including creating new insurance products. “Our teams are uniquely qualified to create new insurance products that push the envelope of what is possible. Our goal is to enable the creation and distribution of insurance solutions that match consumer profiles, offer more flexibility and ultimately cost savings to the consumer while at the same time creating underwriting efficiencies that will eventually drop down to the bottom line, making our collaboration particularly rewarding in the long run,” noted Mr. Shen. In January 2022, FingerMotion became the latest technology company listed on the Nasdaq Capital Market in a move that offered it great exposure within the investment community. Mr. Shen believes that this, coupled with the investments made over the 2021 calendar year, will continue to strengthen the company’s balance sheet and profitability, carrying on the trend posted in Q3 2022. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Keyfest 2022 prompted the question as to whether the Lightning Network is decentralized – the very essence of the layer 2 protocol overlay of the blockchain
• Unlike fiat currency, which is ultimately governed by The Federal Reserve, Bitcoin’s Lightning Network is comprised of nodes and channels with no direct governing body
• The success of the Lightning Network since January 2021 is driving LQwD’s drive for the new year

In a 2015 white paper draft, Joseph Poon and Thaddeus Dryja laid out the Lightning Network for the first time. Two years later, in 2017, the first transaction was made on the layer 2 payment protocol layered on top of a block-based cryptocurrency. Since then, and especially in the past year, the Lightning Network has grown considerably, making transactions among nodes faster and with lower fees. The Lightning Network was among the topics of discussion at Keyfest 2022, organized on January 5-7 by Casa, a Bitcoin custody provider and personalized key manager. At its second edition this year, Keyfest is a virtual festival celebrating the past, present, and future of personal keys. Here, the brightest minds in Bitcoin come together for three days of conversation and workshops discussing a future where everyone owns their wealth, identity, and data. The blockchain itself was created as a decentralized infrastructure, one free of control from the government and other central authorities. The fiat currency system in the United States begins with one central node – The Federal Reserve. The Federal Reserve has the power over the entire process, but it trickles down into supporting nodes and channels – 12 total central banks and 24 supportive branches. The Lightning Network, however, allows anyone to open a channel without any permission required. The prompt for the question was the number of nodes and channels popping up on the Lightning Network. There is a difference in the security of banks and Bitcoin – with Bitcoin requiring public and private keys, making it more secure than the fiat currency bank’s single symmetrical key requirement, it was underlined during the event. LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech company focused on the creation of enterprise-grade infrastructure to drive bitcoin adoption, has developed lqwd.tech, the company’s proprietary platform as a service (“PaaS”) that allows users to execute transactions on the Lightning Network instantly, securely, and with fewer fees. Since the June 2021 acquisition, LQwD has cumulatively acquired over C$9,000,000 (US$7.19 million) worth of Bitcoin as both a reserve and operating asset for the company, some of which is already being used on the Lightning Network. The company’s holdings is around 150 Bitcoin at this time. LQwD has also entered into two strategic service agreements, one with the leading Canadian crypto trading platform Netcoins, Inc., a subsidiary of BIGG Digital Assets Inc., and the other with Breez Development Ltd., an Israeli-based Lightning Network wallet provider. “I wanted to take a moment to recap what has been an active six months for LQwD since listing in June,” LQwD CEO Shone Anstey said (https://ibn.fm/PCuB7). “The remarkable growth of the Lightning Network has validated LQwD’s reason to be hyper-focused on Lightning, and I look forward to continuing to expand our business on this rapidly growing global payment network.” The remarkable growth that Anstey speaks of refers to the multiple milestones reached by the Lightning Network since January 2021, including:

• Node growth of 105% from 770 to 15,000 established nodes
• A Bitcoin capacity increase of 160% (from 1,125 BTC to almost 3,000 BTC)
• Payment channels reached up to 92% established, from 38,000 to 73,000 payment channels

LQwD is now hyper-focused in 2022 on continuing its expansion and on the rapidly growing global payment network. The company expects cryptocurrency’s popularity to continue growing and the Lightning Network to become a force for change worldwide and the global monetary exchange of the future. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Canadian-based clean energy solutions innovator FuelPositive Corp. is developing a means of producing and using ammonia as a non-carbon polluting fuel source
• FuelPositive regards the green ammonia produced by its unique system as a safer and more effective means of transporting hydrogen that can be used to provide power and other benefits in an environmentally positive manner
• The agricultural and shipping industries are preferred targets for conversion because of their heavy carbon fuel use, and some companies are already preparing to transition away from fossil fuels as viable alternatives become available
• The portability of FuelPositive’s solution also makes it an ideal means of providing energy to underserved, remote parts of the planet

As clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) nears launch of its initial proprietary modular system for producing green ammonia, the competition to advance green ammonia technology as a potential alternative to existing greenhouse gas-emitting fuel sources is heating up. A Yale School of the Environment report this month (https://ibn.fm/a2p1n) noted that experimental green ammonia-producing plants powered by large wind or solar farms have been operating in Britain and Japan since 2018, another is planned in the United States by 2023, an Australia plant is aiming to produce 3,500 tons of green ammonia annually by the end of this year, and a Saudi Arabia plant aims to generate 1.2 million tons of it by 2025. In addition, there is the ‘world’s largest green ammonia plant’ planned for South Africa, set to go live in 2025 (https://ibn.fm/oQPT8). “This is a very dynamic field; there’s news out every day,” Melbourne, Australia’s Monash University chemist Douglas Macfarlane stated in the report. Macfarlane, like FuelPositive’s core team, has been working to develop new and much more efficient ways of making green ammonia. FuelPositive’s prototype systems will be fully portable when they roll out later this year with targeted capacity of producing up to 300 kilograms per day of liquid anhydrous green ammonia, which is the approximate amount needed to fertilize and power an 1,800-acre farm. But the output can be increased (or decreased) based on the end user requirements, according to the company, because of the system’s modular and scalable design (https://ibn.fm/CKVNA). One end target is to store hydrogen as green ammonia for effective transportation and storage, with the option of easy conversion back to hydrogen for use in hydrogen fuel cells and other pure hydrogen applications. (FuelPositive’s green ammonia stores 65% more hydrogen than highly compressed pure hydrogen, per unit of storage) Hydrogen is widely regarded as the optimal alternative fuel for weaning industries and consumers off polluting carbon-energy sources that continue to threaten global quality of life amid ongoing climate change. The combustion of 100% green ammonia is also the focus of many studies around the world. The agriculture industry uses about 80 percent of the ammonia produced each year applying carbon-intensive methods for nitrogen-rich fertilizer that improves plant nutrition and crop quality, and ultimately preserves soil fertility, when used properly. (https://ibn.fm/8VcqT). Switching to green ammonia could be transformative for the industry, driving down farming’s carbon footprint by as much as 90 percent for corn and small grain crops, according to the Yale school report. The transition could benefit other industries as well, the consumer product transport industry in particular. A report last year by the International Energy Agency predicted that ammonia will be vital for the shipping industry, which is currently responsible for 3 percent of global emissions (https://ibn.fm/odaVh). Shipping carrier Hoegh Autoliners announced Jan. 20 that it has ordered up to 12 LNG-fueled pure car and truck Aurora-class ships that will be suitable to retrofit to ammonia or methanol propulsion in keeping with its plans to make them the first in the carrier segment to run on green ammonia (https://ibn.fm/54SnU), signaling the industry’s serious intention to explore more environmentally friendly activity. FuelPositive’s modular, scalable platform is also being touted as a solution for providing energy to remote communities thanks to the technology’s portability and efficiency. “Our (Hydrogen-Ammonia Synthesizer) systems are small, they’re about the size of a shipping container that you would see on an ocean-going ship, and we can move them all over the place. So they can be used exactly where the ammonia is needed, so we don’t have to transport ammonia all over the place,” CEO Ian Clifford told a group of young investment advisers last fall (https://ibn.fm/PnbBO). “We think our company will grow a lot in value over the next six to 12 months as our systems are delivered to end users — the people who need the ammonia.” For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Upcoming study supports CYBN’s mission to develop psychedelics into therapeutics.
• Kernel Flow uses pulsed light instead of continuous wave light to increase measured brain information.
• Study may provide crucial “mind-imaging” information that has been previously missing.

Cybin (NEO: CYBN) (NYSE American: CYBN) is starting off the new year right — the company has received approval from an Institutional Review Board (“IRB”) for a feasibility study using Kernel’s quantitative neuroimaging technology, Kernel Flow. Enrollment for the study begins early this year (https://ibn.fm/XTXAe). “By leveraging the Kernel Flow technology, we may have the ability to measure longitudinal brain activity before, during and after a psychedelic experience, and collect quantitative data as opposed to subjective patient reporting,” said Cybin CEO Doug Drysdale. “We believe the results of this study will lead to future studies that will test the effectiveness of psychedelic treatments and will further support our mission to develop psychedelics into therapeutics.” The feasibility study is designed to utilize Kernel’s Flow technology to evaluate ketamine’s psychedelic effect on cerebral cortex hemodynamics (https://ibn.fm/YeDwV). This study could provide crucial information that “may lead to new frontiers in psychedelic therapeutics by enabling the acquisition of longitudinal brain activity before, during and after a psychedelic experience, providing quantification of what was previously subjective patient reporting,” the company noted. “The word psychedelic means ‘mind-manifesting,’ but what has been missing is useful ‘mind-imaging’—the ability to dynamically trace the neural correlates of human conscious experience,” explained Cybin’s chief clinical officer, Dr. Alex Belser. “Conventional neuroimaging just isn’t dynamic enough to study the psychedelic experience in the brain as it happens. This study of ketamine’s psychedelic effects while wearing headgear equipped with sensors to record brain activity could open up new frontiers of understanding.” Kernel’s exclusive tech, called Kernel Flow, uses pulsed light instead of continuous wave light to increase measured brain information. The device used to measure the information is easily wearable, which is a significant difference from electroencephalography (“EEG”) electrodes that typically require gel on the head or functional magnetic resonance imaging (“fMRI”) studies that require a participant to lie in a scanner. The entire system is the size and look of a bicycle helmet and could, in the future, be more broadly used for neuroscientific or physiological studies of brain activity during psychedelic use, noted Cybin. “Quantitatively measuring the brain within the context of a psychedelic experience is a promising frontier,” said Kernel founder and CEO Bryan Johnson. “With Kernel Flow, Cybin’s researchers can start putting numbers and quantification to subjective states of mind, including altered ones.” As a sponsor of the study, Cybin retains an exclusive interest in any innovations that are discovered or developed through its independent analysis of the study findings. Kernel will hold the same rights relating to its Kernel technology. “We hope this feasibility study can bridge the gap of real-time quantitative data collection during psychedelic treatments to further understand the correlation of effects from these powerful molecules,” said Drysdale. “The ability to access real-time brain activity data during a psychedelic experience has tremendous potential for the development of future psychedelic therapeutics.” Cybin is a leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom and Ireland. The company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug-discovery platforms, innovative drug-delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com. NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN

• Chris Bunka, the Chairman and CEO of Lexaria, featured on the EDGE podcast hosted by Brandon C. White
• He provided insight into his background, professional philosophies, and Lexaria’s operations, with a focus on the company’s patented DehydraTECH(TM) technology
• Mr. Bunka also advised small companies and entrepreneurs, citing the importance of understanding the competitive environment

Chris Bunka, the Chairman and Chief Executive Officer (“CEO”) of Lexaria Bioscience (NASDAQ: LEXX), was recently featured on episode 234 of the EDGE Podcast. Hosted by Brandon C. White, an Angel Investor and Entrepreneur, Mr. Bunka shared insights into his professional journey while also sharing what the company is committed to achieving going forward. Mr. Bunka lauded the company’s patented DehydraTECH(TM) technology, citing how integral it is to improve the delivery of active pharmaceutical ingredients and other fat-soluble molecules.  So far, this technology has proven promising for the potential treatment of hypertension and heart disease, and is already being sublicensed for the delivery of CBD. “Our technology is all about enabling a much higher fraction and a much smoother delivery of the beneficial substances in the foods you eat and in the drugs you take and, quite frankly, getting them into your bloodstream,” he noted (https://ibn.fm/kGRDm). He also walked the audience through his career growth that spans over four decades, having started his first business at the age of 17. Over the years, he notes, he has learned how to run a business, rely on other people, and manage employees, skills that have translated to the success of Lexaria thus far. When asked about his most significant career lessons, Mr. Bunka reckoned that while he has learned a lot, the central aspect is the significance of understanding the competitive environment. He further advised small companies and entrepreneurs first to understand their competitive environment and then understand the products and services they offer to customers. “A lot of small companies don’t do a good job of understanding their competitive environment,” he noted. “A lot of them say, ‘I’m the best, I’m the fastest.’…I could be on my laptop and have somebody pitching me on an idea, and I see 3,700 companies just like his. It makes it really hard, so understanding your competitive environment is really, really important, as well as understanding your products and services,” he added. The interview with Mr. Bunka offered a glimpse into the inner workings of Lexaria, the vision that he has for the company, and the goals that it is working towards. In addition, he talked about the company’s ongoing efforts to make the most out of its innovative delivery platform, along with professional philosophies that have guided his career so far. You can listen to the entire interview here https://ibn.fm/3QMBD For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX